Sezary disease is a rare form of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating atypical T-cells. When the disease involves intrapelvic lymph nodes, it indicates a more advanced stage, necessitating accurate coding with ICD-10 Code C84.16 for effective diagnosis, documentation, medical billing, and public health reporting.
ICD-10 Code C84.16 specifically denotes Sezary disease affecting the intrapelvic lymph nodes. This condition is a subtype of cutaneous T-cell lymphoma, where malignant T-cells proliferate, leading to systemic symptoms. This code should be used when documenting cases where the disease has progressed to involve lymph nodes in the pelvic region, ensuring proper billing and clinical management.
Sezary disease, particularly when involving intrapelvic lymph nodes, is a serious hematological malignancy that requires prompt medical intervention. It is characterized by the proliferation of malignant T-cells, leading to significant morbidity. Early recognition and accurate coding with ICD-10 Code C84.16 are essential for effective treatment and management.
In clinical workflows, ICD-10 Code C84.16 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is crucial for both acute and chronic care settings, ensuring comprehensive documentation and facilitating appropriate billing.
In SOAP notes, ICD-10 Code C84.16 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Sezary disease affecting intrapelvic lymph nodes. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Sezary disease involving intrapelvic lymph nodes requires urgent medical attention and may necessitate hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.16 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance |
| 99214 | Established patient office visit, moderate complexity |
| 85025 | Complete blood count with automated differential white blood cell count |
Common Questions About Using ICD-10 Code C84.16 for Sezary disease, intrapelvic lymph nodes
What are the common symptoms of Sezary disease?
Common symptoms include widespread skin redness, severe itching, swollen lymph nodes, and systemic symptoms like fatigue and weight loss. These symptoms can significantly impact the patient's quality of life.
How is Sezary disease diagnosed?
Diagnosis typically involves a combination of clinical evaluation, skin biopsy, and blood tests to identify atypical T-cells. Imaging studies may also be used to assess lymph node involvement.
What treatment options are available for Sezary disease?
Treatment may include systemic therapies such as chemotherapy, targeted therapy, and immunotherapy. Supportive care is also essential to manage symptoms and improve quality of life.
Is Sezary disease contagious?
No, Sezary disease is not contagious. It is a malignancy of T-cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes